Article Information
History
- December 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Wanwisa Dejnirattisai1,2,*,
- Robert H Shaw3,*,
- Piyada Supasa1,*,
- Chang Liu1,2,
- Arabella SV Stuart3,
- Andrew J Pollard3,4,
- Xinxue Liu3,
- Teresa Lambe2,3,
- Derrick Crook4,5,
- Dave I Stuart1,2,6,7,8,
- Juthathip Mongkolsapaya1,2,9,
- Jonathan S Nguyen-Van-Tam10,
- Matthew D Snape3,4,#&,
- Gavin R Screaton1,2,#,
- the Com-COV2 study group
- 1Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 2Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK
- 3Oxford Vaccine Group, Department of Paediatrics, University of Oxford
- 4NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK
- 5Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 6Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK
- 7Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK
- 8Instruct-ERIC, Oxford House, Parkway Court, John Smith Drive, Oxford, UK
- 9Siriraj Center of Research Excellence in Dengue & Emerging Pathogens, Dean Office for Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- 10Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham, UK
- ↵&corresponding author; email: matthew.snape{at}paediatrics.ox.ac.uk
↵* contributed equally and are joint first authors